IMMUSOFT CORP

Profile

Company Names

IMMUSOFT CORP

Addresses

454 N. 34TH STREET, SEATTLE, WA 98103

2800 ELLIOTT AVENUE, SUITE 414, SEATTLE, WA 98121

Phone Numbers

206-931-0262

 

Entity Type:

CORPORATION

Industry:

OTHER, BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

WASHINGTON

Total Amount Raised:

$40,517,981.00

Number of Funding Rounds:

6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2024-05-28 
$4,583,668.00 
$10,000,000.00 
$5,416,332.00 
Equity 
5
2020-09-08 
$10,274,850.00 
$11,000,000.00 
$725,150.00 
Equity 
4
2018-01-04 
$20,170,006.00 
$23,376,522.00 
$3,206,516.00 
Equity 
3
2016-10-18 
$2,739,999.00 
$4,594,068.00 
$1,854,069.00 
Equity 
2
2015-08-03 
$375,000.00 
$1,000,000.00 
$625,000.00 
Debt 
1
2014-08-06 
$2,374,458.00 
$3,286,771.00 
$912,313.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MARK 
 
AHN, PH.D. 
DIRECTOR
IMMUSOFT CORP
SEAN 
 
AINSWORTH 
EXECUTIVE OFFICER, DIRECTOR
RETROSENSE THERAPEUTICS, LLC   |  IMMUSOFT CORP   |  OCUPHIRE PHARMA, INC.   |  OCUPHIRE PHARMA, INC.   |  RAY THERAPEUTICS, INC.   |  OPUS GENETICS, INC.
SEAN 
C/O 
AINSWORTH 
EXECUTIVE OFFICER, DIRECTOR
IMMUSOFT CORP
RICHARD 
 
CHIN, M.D. 
DIRECTOR
GALENA BIOPHARMA, INC.   |  IMMUSOFT CORP   |  NACUITY PHARMACEUTICALS, INC.
CAM 
 
GALLAHGER 
DIRECTOR
IMMUSOFT CORP
ERIC 
 
GARCIA 
EXECUTIVE OFFICER
HARVEST GROWTH CAPITAL LLC   |  IMMUSOFT CORP   |  HARVEST CLARO, LLC   |  HARVEST GROWTH CAPITAL III LLC   |  OISIN BIOTECHNOLOGIES, INC.   |  ONCOSENX, INC.   |  HARVEST GROWTH CAPITAL IV QP LLC   |  HARVEST GROWTH CAPITAL IV LLC   |  PRIMARY HARVEST CHIEF, LLC
ERIC 
 
HERBIG 
EXECUTIVE OFFICER
IMMUSOFT CORP
WENDELL 
 
KING 
DIRECTOR
RECOMBINETICS, INC   |  IMMUSOFT CORP
SCOTT 
 
MCIVOR 
EXECUTIVE OFFICER
IMMUSOFT CORP
JULIA 
 
MOORE 
DIRECTOR
IMMUSOFT CORP   |  CHECKERSPOT, INC.   |  VITRA LABS, INC.   |  BREAKOUT VENTURES III, L.P. /DE   |  BREAKOUT VENTURES III-B, L.P.
MATTHEW 
 
SCHOLZ 
EXECUTIVE OFFICER, DIRECTOR
IMMUSOFT CORP   |  ONCOSENX, INC.   |  OISIN BIOTECHNOLOGIES, INC.
ANTHONY 
 
SUN 
DIRECTOR
CENERX BIOPHARMA INC   |  NEOCONIX INC   |  BRIDGE PHARMACEUTICALS, INC.   |  LAVANTE INC   |  CANESTA INC   |  VERSARTIS, INC.   |  PACKET PHOTONICS, INC.   |  IMMUSOFT CORP   |  EYENOVIA, INC.   |  ALLOY THERAPEUTICS, INC.
RICH 
 
VINCENT 
EXECUTIVE OFFICER
CHUMBY INDUSTRIES INC   |  IMMUSOFT CORP   |  MEDCURA, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-06-12
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2024-05-28 
2021-03-02
D/A
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2020-09-08 
2020-09-23
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2020-09-08 
2019-01-25
D/A
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2018-01-04 
2018-01-18
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2018-01-04 
2016-11-01
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2016-10-18 
2015-08-18
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2015-08-03 
2014-08-20
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-08-06 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#